Search Results - "HAMORI, T"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    New non competitive AMPA antagonists by ABRAHAM, G, SOLYOM, S, KAPUS, G, HARSING, L. G, KIRALY, I, PATTHY, M, HORVATH, G, CSUZDI, E, BERZSENYI, P, LING, I, TARNAWA, I, HAMORI, T, PALLAGI, I, HORVATH, K, ANDRASI, F

    Published in Bioorganic & medicinal chemistry (01-08-2000)
    “…New halogen atom substituted 2,3-benzodiazepine derivatives condensed with an azole ring on the seven membered part of the ring system of type 3 and 4 as well…”
    Get full text
    Journal Article
  2. 2

    Anxiolytic 2,3-benzodiazepines, their specific binding to the basal ganglia by Horváth, E J, Horváth, K, Hámori, T, Fekete, M I, Sólyom, S, Palkovits, M

    Published in Progress in neurobiology (01-03-2000)
    “…Over the past 20 years, several members of the 2,3-benzodiazepine family have been synthesized. Some of these compounds--tofisopam (Grandaxin), girisopam,…”
    Get full text
    Journal Article
  3. 3

    Structural analogues of some highly active non-competitive AMPA antagonists by Hámori, T, Sólyom, S, Berzsenyi, P, Andrási, F, Tarnawa, I

    Published in Bioorganic & medicinal chemistry letters (01-05-2000)
    “…Some 5-methyl analogues (14a-e) of the non-competitive AMPA antagonists 3-acylated 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-4,5-dihydro-3H-2,3-benzodi…”
    Get full text
    Journal Article
  4. 4

    Omeprazole and talampanel as two examples of retrometabolic drug design by Andrási, F, Berzsenyi, P, Farkas, L, Körösi, J, Hámori, T, Botka, P, Ling, I, Láng, T

    Published in Pharmazie (01-05-2004)
    “…The goal of retrometabolic drug design is: "to design safe, locally active compounds with an improved therapeutic index". Here we describe two cases from our…”
    Get more information
    Journal Article
  5. 5

    Neuropharmacology of a new psychotropic 2,3-benzodiazepine by Andrási, F, Horváth, K, Sineger, E, Berzsenyi, P, Borsy, J, Kenessey, A, Tarr, M, Láng, T, Kórösi, J, Hámori, T

    Published in Arzneimittel-Forschung (01-10-1987)
    “…1-(3-Chlorophenyl)-4-methyl-7,8-dimethoxy-5H-2,3-benzodiazepine (GYKI 51189) is a new analogue of tofisopam. Due to the novel chemical structure this molecule…”
    Get more information
    Journal Article
  6. 6

    A new psychoactive 5H-2,3-benzodiazepine with a unique spectrum of activity by Horváth, K, Andrási, F, Berzsenyi, P, Pátfalusi, M, Patthy, M, Szabó, G, Sebestyén, L, Bagdy, E, Körösi, J, Botka, P

    Published in Arzneimittel-Forschung (01-08-1989)
    “…The neuropharmacological effects of 1-(4-amino-phenyl)-4-methyl-7,8-dimethoxy-5H-2,3-benzodiazepine (GYKI 52 322) were investigated and compared with those of…”
    Get more information
    Journal Article
  7. 7

    Anxiolytic profile of girisopam and GYKI 52,322 (EGIS 6775). Comparison with chlordiazepoxide and buspirone by Horváth, K, Andrási, F, Botka, P, Hámori, T

    Published in Acta physiologica Hungarica (1992)
    “…The anxiolytic action of two 2,3-benzodiazepines: girisopam: GYKI 51,189 (EGIS 5810): (1-(3-chlorophenyl)-4-methyl-7,8-dimethoxy-5H-2,3-benzodiazepine), and…”
    Get more information
    Journal Article
  8. 8